Performance analysis of Crescent Biopharma (CBIO)
Annual Return
Since Jun 13, 2025, CBIO has had an average annual return of +12.75%, underperforming the benchmark SPY, which returned +28.65% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +51.60% | -25.87% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.14% | +26.06% | +51.95% | +21.78% | -7.69% | -12.92% | +51.60% | ||||||
| 2025 | +0.88% | -23.05% | +15.93% | -17.43% | +7.24% | +18.03% | -21.19% | -25.87% |
Drawdown analysis of Crescent Biopharma (CBIO)
The maximum drawdown for the CBIO was -50.33%, occurring on Feb 13, 2026. Recovery took 31 trading sessions.
The current CBIO drawdown is -33.36%.
Since Jun 13, 2025 CBIO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -50.33% | Jun 25, 2025 | 161 | Feb 13, 2026 | 31 | Mar 31, 2026 | 192 |
| -36.97% | Apr 22, 2026 | 28 | Jun 2, 2026 | Ongoing | Ongoing | Ongoing |
| -17.06% | Jun 13, 2025 | 2 | Jun 17, 2025 | 5 | Jun 25, 2025 | 7 |
| -7.27% | Apr 2, 2026 | 6 | Apr 13, 2026 | 1 | Apr 14, 2026 | 7 |
| -2.51% | Apr 15, 2026 | 1 | Apr 16, 2026 | 1 | Apr 17, 2026 | 2 |